.
Join us for This Upcoming
Virtual Education Program
A Focus on Type 2 Inflammation in Disease
Presented by Regeneron
Wednesday, March 24, 2021 | 8:00 PM
Speaker: Myron Zitt, MD
Presented by Regeneron
Wednesday, March 24, 2021 | 8:00 PM
Speaker: Myron Zitt, MD
You may also RSVP by contacting Keith Orlandini at 267-377-9041 or keith.orlandini@regeneron.com
Upcoming 2021 Virtual Programs
A Focus on Type 2 Inflammation in Chronic Rhinosinusitis With Nasal Polyposis
Tuesday, May 11, 2021 | 8:00 PM
Presented by Regeneron
Speaker: John Oppenheimer, MD, UMDNJ Rutgers
Please RSVP to Keith Orlandini at 267-377-9041 or keith.orlandini@regeneron.com
Click here for more information.
Tuesday, May 11, 2021 | 8:00 PM
Presented by Regeneron
Speaker: John Oppenheimer, MD, UMDNJ Rutgers
Please RSVP to Keith Orlandini at 267-377-9041 or keith.orlandini@regeneron.com
Click here for more information.
Past Virtual Education Programs
Treatment of Chronic Idiopathic Urticaria in Patients Symptomatic Despite H1 Antihistamines
Presented by Genentech
Thursday, December 10, 2020
A Brief Review of Clinical and Real-World Evidence for Using a Biologic to Treat Severe Eosinophilic Asthma
Presented by GSK
Wednesday, November 18, 2020
Diagnosis and Management of Chronic Granulomatous Disease
Presented by Horizon Pharmaceuticals
Wednesday, November 4, 2020
Dupixent® (dupliumab) and the Role of Type 2 Inflammation in Asthma, Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP), and Atopic Dermatitis
Presented by Regeneron
Wednesday, October 21, 2020
A Brief Review of Clinical and Real-World Evidence for Using a Biologic to Treat Severe Eosinophilic Asthma
Presented by GSK
Wednesday, October 7, 2020
A Focus on Type 2 Inflammation in Disease
Presented by Regeneron
Thursday, September 24, 2020
Advancements in Atopic Dermatitis: What Do They Mean For Your Practice?
Presented by The France Foundation
Wednesday, September 2, 2020
Rethinking the Management of Allergic Asthma: A Case-Based Interactive Approach to Diagnosis and Treatment
Presented by Genentech
Thursday, August 20, 2020
Inflammation and Disease Pathophysiology of Chronic Rhinosinusitis with Nasal Polyps (CRS with NP)
Presented by Regeneron
Wednesday, August 12, 2020
Uncontrolled Asthma - Changing the Patient Experience
Presented by GSK
Thursday, July 30, 2020
Watch the recording now.
Type 2 Inflammation in Asthma
Presented by Regeneron
Wednesday, July 22, 2020
Presented by Genentech
Thursday, December 10, 2020
A Brief Review of Clinical and Real-World Evidence for Using a Biologic to Treat Severe Eosinophilic Asthma
Presented by GSK
Wednesday, November 18, 2020
Diagnosis and Management of Chronic Granulomatous Disease
Presented by Horizon Pharmaceuticals
Wednesday, November 4, 2020
Dupixent® (dupliumab) and the Role of Type 2 Inflammation in Asthma, Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP), and Atopic Dermatitis
Presented by Regeneron
Wednesday, October 21, 2020
A Brief Review of Clinical and Real-World Evidence for Using a Biologic to Treat Severe Eosinophilic Asthma
Presented by GSK
Wednesday, October 7, 2020
A Focus on Type 2 Inflammation in Disease
Presented by Regeneron
Thursday, September 24, 2020
Advancements in Atopic Dermatitis: What Do They Mean For Your Practice?
Presented by The France Foundation
Wednesday, September 2, 2020
Rethinking the Management of Allergic Asthma: A Case-Based Interactive Approach to Diagnosis and Treatment
Presented by Genentech
Thursday, August 20, 2020
Inflammation and Disease Pathophysiology of Chronic Rhinosinusitis with Nasal Polyps (CRS with NP)
Presented by Regeneron
Wednesday, August 12, 2020
Uncontrolled Asthma - Changing the Patient Experience
Presented by GSK
Thursday, July 30, 2020
Watch the recording now.
Type 2 Inflammation in Asthma
Presented by Regeneron
Wednesday, July 22, 2020
Questions?
For other questions and more information, please contact the PAAA Meeting Manager, Lauren Newmaster at lnewmaster@pamedsoc.org
or (717) 909-2691.
For other questions and more information, please contact the PAAA Meeting Manager, Lauren Newmaster at lnewmaster@pamedsoc.org
or (717) 909-2691.